Monopar CFO exercises RSUs, covers tax with shares
Monopar Therapeutics’ Chief Financial Officer Vu Quan Anh reported routine equity compensation activity tied to restricted stock units.
Rhea-AI Filing Summary
Monopar Therapeutics’ Chief Financial Officer Vu Quan Anh reported routine equity compensation activity tied to restricted stock units. On the vesting date, 1,228 restricted stock units converted into the same number of common shares. The company withheld 507 shares to cover tax obligations, a non‑market disposition.
Following these transactions, Vu Quan Anh directly holds 2,221 shares of common stock. He also retains 8,598 unvested restricted stock units from a 9,826-unit grant awarded on December 2, 2025, which began vesting on June 30, 2026 and is scheduled to fully vest by December 31, 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,228 shares exercised/converted
Exercise
3 txns
Insider
Vu Quan Anh
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 1,228 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,228 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 507 | $92.59 | $47K |
Holdings After Transaction:
Restricted Stock Unit — 8,598 contracts (Direct);
Common Stock — 2,221 shares (Direct)
Footnotes (3)
- F1. Represents shares acquired on vesting and settlement of restricted stock units.
- F2. Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- F3. On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Key Figures
RSUs vested: 1,228 shares
Shares withheld for tax: 507 shares at $92.59
Common shares held after: 2,221 shares
+4 more
7 metrics
RSUs vested
1,228 shares
Restricted stock units converted to common stock on June 30, 2026
Shares withheld for tax
507 shares at $92.59
Withheld by issuer to pay RSU-related withholding tax
Common shares held after
2,221 shares
Direct ownership following RSU vesting and tax withholding
Original RSU grant
9,826 units
Grant awarded on December 2, 2025 to CFO Vu Quan Anh
Unvested RSUs remaining
8,598 units
RSUs still outstanding after 1,228 vested and settled
Initial vesting tranche
6/48ths (1,228 units)
First vesting on June 30, 2026 from RSU grant
Ongoing vesting schedule
3/48ths every 3 months
Quarterly vesting until December 31, 2029
Key Terms
Restricted Stock Unit, withholding tax, vested, derivative security, +1 more
5 terms
Restricted Stock Unit financial
"On December 2, 2025, the reporting person was granted 9,826 restricted stock units"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
withholding tax financial
"shares withheld by the issuer to pay for the applicable withholding tax due"
Withholding tax is a government-required portion of a payment—such as dividends, interest, or salary—that the payer keeps back and sends directly to tax authorities before the recipient receives the money. For investors it reduces the cash they actually get and changes the after-tax return on an investment; rates and refund or credit rules vary by country and can materially affect comparisons between similar investments, like a cashier holding part of a bill to cover taxes.
vested financial
"vested 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Monopar Therapeutics (MNPR) report for its CFO?
Monopar Therapeutics’ CFO Vu Quan Anh reported RSU vesting and related tax withholding. 1,228 restricted stock units converted into common shares, and 507 shares were withheld to cover taxes, leaving him with 2,221 common shares held directly.
What RSU grant underlies the Monopar Therapeutics (MNPR) CFO’s Form 4 filing?
The filing relates to a grant of 9,826 restricted stock units awarded on December 2, 2025. These units vest 6/48ths (1,228 units) on June 30, 2026 and 3/48ths every three months until full vesting on December 31, 2029.
How many unvested RSUs does the Monopar Therapeutics (MNPR) CFO still hold?
After 1,228 RSUs vested and settled into common shares, the CFO retains 8,598 unvested restricted stock units. These remaining RSUs continue to vest quarterly through December 31, 2029 under the original grant schedule.
What does the tax-withholding transaction mean in the Monopar Therapeutics (MNPR) Form 4?
The tax-withholding entry reflects 507 shares withheld by Monopar Therapeutics to satisfy withholding tax due at RSU vesting. This is an automatic mechanism to pay taxes, not an open-market sale initiated by the CFO.
AI-generated analysis. How Rhea-AI works. Not financial advice.
